Company news

NewcelX Ltd. news in 2025

NewcelX Ltd.'s news releases, calls and decks from 2025, newest first.

View company

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

December 10, 2025

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

November 16, 2025

NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board

November 5, 2025

NewcelX CEO Issues Letter to Shareholders

November 3, 2025

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

November 3, 2025

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger

October 30, 2025

Decks in 2025